Shipments will halt by close of business Tuesday evening, the company said. Sarepta had initially rejected the agency’s ...

Shares fell 75% to $3.04, putting the stock on track for a record closing low, according to Dow Jones Market Data. The stock ...

The FDA sent letters to companies selling products with concentrated 7-hydroxymitragynine, which is illegal to market.

The Food and Drug Administration’s (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) voted 10-1 against the approval of brexpiprazole in combination with sertraline for the treatment of adults ...

The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Coca-Cola is making a version with cane sugar instead of high-fructose corn syrup. Here’s what research says about its health ...

Replimune shares collapsed on Tuesday after the U.S. Food and Drug Administration rejected the clinical-stage biotechnology company's proposed advanced melanoma treatment. Shares of the Woburn, Mass., ...

Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...

Pennsylvania-based A.P. Deauville, LLC is recalling several types of its Power Stick deodorant, due to a process issue.

Curcumin, the active ingredient in the spice turmeric, hasn’t been clinically proven to slow disease progression in people with dementia or Alzheimer’s disease, but researchers believe it has some ...

The US Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete and unnecessary." ...